Biglycan™ is a trademark of Pharmahungary
Biglycan™ therapy: open for out-licensing and/or co-development partnership
Use of biglycan or enhancers of biglycan activity in the preparation of pharmaceutical compositions
Summary of invention: The present invention relates to the use of biglycan or enhancers of biglycan activity in the preparation of pharmaceutical compositions having anti-atherosclerotic, anti-ischemic effect, and cytoprotective effect and to the use of them in methods for preventing and treating the atherosclerotic and ischemic (e.g. cardiac) diseases. The invention also relates to screening methods by which biglycan or enhancers of biglycan activity can be identified.
Patented technology, primary filing date: Jan 2007; PCT filing date: Jan 2008; currently in national phases wordwide.